APA (7th ed.) Citation

Pan, S., Pan, S., Wang, J., Wang, J., Tian, J., Tian, J., . . . Meng, F. Safety and efficacy of PD-1 inhibitors plus tyrosine kinase inhibitors combination therapy in patients with advanced hepatocellular carcinoma combined with hyperbilirubinemia: A retrospective cohort study. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Pan, Shida, et al. Safety and Efficacy of PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Combination Therapy in Patients with Advanced Hepatocellular Carcinoma Combined with Hyperbilirubinemia: A Retrospective Cohort Study. Frontiers Media S.A.

MLA (9th ed.) Citation

Pan, Shida, et al. Safety and Efficacy of PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Combination Therapy in Patients with Advanced Hepatocellular Carcinoma Combined with Hyperbilirubinemia: A Retrospective Cohort Study. Frontiers Media S.A.